Pharmafile Logo

Competition from within

August 25, 2015 | emerging markets 

Published in eyeforpharma July 29 by Rachel Howard

To what extent can Big Pharma expect to face an increasing challenge from globalizing pharmaceutical companies based in emerging markets?

If we take a look at the top 50 pharmaceutical companies of 2013, they are mainly headquartered in North America (18), the EU (18) or Japan (9). Teva (Israel), CSL (Australia) and Aspen (South Africa) are notable exceptions, with the Indian generic giants Sun and Ranbaxy – which have since merged – the only representation from the ‘BRIC’ markets (Brazil, Russia, India and China). In ten years’ time, will more ‘home-grown’ emerging market companies feature on this list?

In this article, I will explore and compare the directions the domestic pharmaceutical industries of South Korea, China and Brazil have taken in recent years, and consider what threat, if any, each poses to established pharmaceutical companies on a global scale.

Read the full article here http://www.researchpartnership.com/news/2015/07/competition-from-within/

This content was provided by Inizio

Company Details

 Latest Content from  Inizio 

Infographic: Therapy Watch Psoriasis

Our PsO infographic offers an introduction to the real-world patient insights collected by our Therapy Watch PsO study.

Article: How behavioural economics can help you build better brand communications

For pharma marketers, accelerating brand performance means maximizing return on investment. Your campaigns need to trigger the right emotions, and the right actions, in your audience.

Article: From KOLs to KOIs – How to identify and engage the new healthcare influencers

Paul Reed and Basil Feilding investigate a new breed of KOLs with online influence and explain why pharma needs to join the conversation.

New syndicated patient reports –

Living with Uterine Fibroids and Endometriosis US 2022

Webcast: From perceptions to prescribing: Combining forces with next-generation tracking and benchmarking to accelerate brand performance

In this webcast we demonstrate RP and STEM's integrated approaches which gives clients the level of insights they need to accelerate brand performance.

EVOKE MIND+MATTER BOLSTERS SENIOR TEAM WITH TRIO OF STRATEGIC HIRES

*Mohinder Mann joins as Associate Medical Director *Nicole Moores joins as Associate Director, Pharma & Lifesciences *Sharron Woods joins as Associate Director, Animal Health Evoke Mind+Matter has continued to strengthen...

Animation: Living With

The journey from the patient's perspective

Infographic: Therapy Watch Lupus

Download our latest infographic, which offers an introduction to the real-world patient insights collected by our Therapy Watch Lupus study.

Article: Getting their lives back: Improving options for people with Lupus

Head of Therapy Watch, Helen Parfitt and Head of Living With, Mariel Metcalfe, investigate Lupus from the perspective of both healthcare professionals and patients using data from our syndicated products.

Evoke Kyne Named Communiqué Communications Consultancy of the Year 2021

Evoke KYNE took home the Communiqué Communications Consultancy of the Year award at the 2021 Communiqué Awards held on 1 September at the Grosvenor House hotel in London.David Kyne, CEO, Evoke KYNE said:...